Sökresultat

Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly discovered genetic risk factor that might be specific to people in the southern part of Sweden. And is coffee really protective? Tell us about your research! “My research

https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2026-04-21

After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic stem cells were transplanted into the first Parkinson's patient at Skåne University Hospital. During the autumn 2022, the Swedish MPA (Läkemedelsverket) approved the clinical STEM-PD study. Several of MultiParks PIs hav

https://www.multipark.lu.se/article/stem-pd-bench-bedside-story-multipark-researchers-0 - 2026-04-21

Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional journey? Listen to MultiPark’s new podcast series “Meet our scientists”! In a newly launched podcast, young MultiPark researchers interview our research group leaders about their academic journey and main scientific foc

https://www.multipark.lu.se/article/meet-our-scientists-new-podcast-young-multipark-researchers - 2026-04-21

In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's patients. Thanks to the pioneering basic research at MultiPark, stemcell-derived neural cells can now be tested in a clinical trial for the first time. In Parkinson's disease, the nerve cells in an area of the brain that con

https://www.multipark.lu.se/article/world-parkinsons-day-transplantations-parkinsons-disease-time-travel - 2026-04-21

Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neurodegenerative diseases is a new special interest group (SIG) addressing scientific and technological needs to unravel the genetics behind diseases such as Parkinson’s and Alzheimer’s. Andreas Puschmann tells about how h

https://www.multipark.lu.se/article/genetics-neurodegenerative-diseases-special-interest-group - 2026-04-21

Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. Two of them are MultiPark research leaders. They do research on chaperone proteins’ function in neurodegenerative diseases and blood tests for rapid screening of drugs in the treat

https://www.multipark.lu.se/article/double-success-multipark-research-groups-prestigious-eu-grant-round - 2026-04-21

Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceutical symposium sponsored by MultiPark. Sarah Tabrizi, a high profile Huntington researcher, and some of MultiPark's own researchers will speak. Medications are the physician's primary tool when treating their patients,

https://www.multipark.lu.se/article/superstars-coming-lund-pharmaceutical-symposium-sponsored-multipark - 2026-04-21

Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired brain injuries and their links to neurodegeneration diseases” is a new special interest group (SIG) collaborating across research groups to elucidate molecular processes that may mediate the relation between acquired bra

https://www.multipark.lu.se/article/acquired-brain-injuries-special-interest-group - 2026-04-21

Thanks to the recent development of diagnostic tools based on blood biomarkers linked to Alzheimer’s, it is possible to predict whether an individual will develop the disease. Therefore, MultiPark researchers gather across groups to investigate hidden opportunities and develop implementable tools also for other brain conditions with similar approaches. “Development and implementation of fluid biom

https://www.multipark.lu.se/article/fluid-biomarkers-special-interest-group - 2026-04-21

In April, the young MultiPark working group organized a photo competition entitled "Brain in Picture". The external jury has had a hard time choosing, but now, they have appointed the best entry. Congratulations to Ellinor Molnár, bachelor student in the Behavioral Neuroscience Laboratory, for a great picture and for winning the competition! The jury had the following motivation: The winning entry

https://www.multipark.lu.se/article/brain-picture-winning-photo - 2026-04-21

New research is underway at Lund University, led by Dr. Vivien Horvath, a postdoctoral researcher at Lund Stem Cell Center. Supported by a new grant from the Collaborative Center for X-Linked Dystonia-Parkinsonism (XDP), Vivien aims to improve our understanding of XDP, a rare neurodegenerative disorder caused by the recent insertion of a transposable element. Transposable elements, also known as '

https://www.multipark.lu.se/article/exploring-role-jumping-genes-x-linked-dystonia-parkinsonism - 2026-04-21

Fredrik Nilsson defended his Ph.D. thesis on May 10, 2023. For the last four years, he has explored the use of patient-specific cells in cell replacement therapy for Parkinson's disease to identify strategies to safeguard these transplanted cells from disease-related degeneration. Now, he tells us about his findings, their potential implications for future therapies, and valuable insights and advi

https://www.multipark.lu.se/article/cell-replacement-therapy-parkinsons-disease-phd-interview-fredrik-nilsson - 2026-04-21

One of Multipark's associated research groups has published a new study that reveals the role of astrocytes in the development of frontotemporal dementia (FTD). Their findings, now in the journal Brain Communications, provide valuable insights into the cellular mechanisms of the disease and open up new possibilities for developing early diagnostics and potential interventions for patients with FTD

https://www.multipark.lu.se/article/new-study-reveals-astrocytes-role-frontotemporal-dementia - 2026-04-21

Summer is the right period for recharging our batteries through vacations and travels. It also seems to be an attractive time to organize scientific conferences… Here are some warm summer wishes from three MultiPark research group leaders and the MultiPark management team attending the World Parkinson Congress in Barcelona. Every third year, the World Parkinson Coalition organizes a breathtaking m

https://www.multipark.lu.se/article/summer-greetings-multipark-world-parkinson-congress - 2026-04-21

Lewy body disease is the second most common neurodegenerative disease after Alzheimer's disease. A research group from Lund University has now shown that the disease can be detected before symptoms appear, using a spinal fluid test. The studies are published in Nature Medicine, where the researchers also demonstrate that reduced sense of smell is strongly linked to Lewy body disease even before ot

https://www.multipark.lu.se/article/lewy-body-disease-can-be-detected-symptoms - 2026-04-21

Researchers at Lund and Gothenburg Universities have successfully developed temporary, organic electrodes that can be seamlessly integrated into biological systems. The method, now published in Nature Communications, opens up a future where bioelectronics can be implanted in and removed from the body without surgery. Electrotherapy is a medical treatment method that uses electrical currents to sti

https://www.multipark.lu.se/article/electrotherapy-without-surgery - 2026-04-21

Researchers at Lund University have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats. They have then used the information to measure what happens to the neurons when the rats are given psychedelic drugs. The results show an unexpected and simultaneous synchronisation among neurons in several regions of the brain. In light of the develo

https://www.multipark.lu.se/article/how-psychedelic-drugs-affect-rats-brain - 2026-04-21

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. När konferenser hålls digitalt till exempel via Zoom eller Teams så gäller delvis andra momsregler än när konferensen hålls på plats i Sverige. När utländska deltagare är med digitalt från sitt eget land så gäller huvudregeln för moms: De som har VAT-nummer eller motsvarande momsregistreringsnummer: Omvänd beskattni

https://www.ekonomiwebben.lu.se/artikel/momsregler-vid-digitala-konferenser - 2026-04-21

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. Den 3 december bjuder sektionen Ekonomi in till Ekonomidagen. I år hålls den digitalt. Läs mer om programmet och hur du anmäler dig i inbjudan här på Ekonomiwebben. Senaste anmälningsdatum är 27 november. Programmet och länk till anmälan

https://www.ekonomiwebben.lu.se/artikel/valkommen-pa-ekonomidagen-2 - 2026-04-21

Den här artikeln är över 5 år gammal, och informationen kan därför vara inaktuell. Tillfälligt höjt maxbelopp detta år. Universitetet har beslutat att det är skattefrihet för julklappar upp till ett värde av 1 000 kronor inkl. moms per anställd i år på grund av coronapandemin. Enligt regelverket är beloppet på julgåva 450 kr inkl. moms i normala fall. Det tillfälliga beloppet gäller till och med 2

https://www.ekonomiwebben.lu.se/artikel/speciella-regler-julklappar-till-anstallda-2020 - 2026-04-21